Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Goodwill (2016 - 2017)

Soleno Therapeutics has reported Goodwill over the past 3 years, most recently at $718000.0 for Q1 2017.

  • Quarterly Goodwill changed 0.0% to $718000.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $718000.0 through Mar 2017, changed 0.0% year-over-year, with the annual reading at $718000.0 for FY2016, 21.68% down from the prior year.
  • Goodwill was $718000.0 for Q1 2017 at Soleno Therapeutics, roughly flat from $718000.0 in the prior quarter.
  • Over five years, Goodwill peaked at $916807.0 in Q4 2015 and troughed at $718000.0 in Q3 2015.
  • The 3-year median for Goodwill is $718000.0 (2015), against an average of $746401.0.
  • The largest YoY upside for Goodwill was 0.0% in 2016 against a maximum downside of 21.68% in 2016.
  • A 3-year view of Goodwill shows it stood at $916807.0 in 2015, then fell by 21.68% to $718000.0 in 2016, then changed by 0.0% to $718000.0 in 2017.
  • Per Business Quant, the three most recent readings for SLNO's Goodwill are $718000.0 (Q1 2017), $718000.0 (Q4 2016), and $718000.0 (Q3 2016).